about
Accuracy and completeness of drug information in Wikipedia: a comparison with standard textbooks of pharmacologyCardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failureAlanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteersImpairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutantsSubstrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental SubstratesEffect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat heartsCurrent understanding of the pharmacogenomics of metformin.Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.Functionalized silicon quantum dots tailored for targeted siRNA delivery.Beta-adrenergic stimulation induces cardiac ankyrin repeat protein expression: involvement of protein kinase A and calmodulin-dependent kinase.Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.ATP-binding cassette transporters in the heart.The ubiquitin-proteasome system: focus on the heart.Drug transport by breast cancer resistance protein.Personalizing antiplatelet therapy with clopidogrel.Understanding platinum-induced ototoxicity.Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.Gender is an important determinant of the disposition of the loop diuretic torasemide.Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes.Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes.N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.Drug transporter regulation in tumors by DNA methylation.Functional coupling of overexpressed beta 1-adrenoceptors in the myocardium of transgenic mice.Interventions for managing medication-related osteonecrosis of the jaw.Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics.Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization.Focused screening of a panel of cancer-related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia.Activation of the cardiac endothelin system in left ventricular hypertrophy before onset of heart failure in TG(mREN2)27 rats.Augmented expression of cardiotrophin-1 in failing human hearts is accompanied by diminished glycoprotein 130 receptor protein abundance.Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.[Risperidone][Citalopram]The impact of hyoscine-N-butylbromide on adenoma detection during colonoscopy: meta-analysis of randomized, controlled studies.Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue.
P50
Q21090592-B12EB6F4-7EF1-4D08-A5D9-45E6D4E3BE74Q24299316-C9599A28-BFCB-4950-86CA-6DF8FE568879Q24338511-418B0930-3697-42ED-BB25-18FCBC238112Q28239896-2C707481-6A6E-4B6A-A2F6-DCE098F576EEQ28547662-8E560139-A5D8-4BE5-A969-44CB3CE3C6B5Q28579209-DE8EF238-2C7A-4394-B107-36E257C4DD6EQ29473677-8F689CE9-F9DC-4EB1-B113-7292027A8DB2Q31873906-800CD726-9942-4801-B566-4CA8C014FC98Q33478192-2C9D3C0C-7D72-4994-BEFF-DB9A0939F05EQ34263774-AF9EE758-C6B9-4CBB-94AF-A30574892D47Q35027144-16EFFD8C-474D-468E-B3B8-42C76DDB9A95Q35601874-E66A2A2F-96C4-4C7B-840F-7CD58E6C338FQ36357762-0B44FCE6-CAC6-4CB4-BD37-8DC5A4C9E427Q36404525-CB58CB41-7B52-4AB3-9EAE-55308273E932Q37793056-20D7D783-51F6-4546-A822-5DDFCF671AF0Q38040698-274AFFBF-9B70-4449-BCAD-4581ED83657EQ38114654-B84D03D5-3414-4DAD-91D0-7BFC43CEE7A5Q38489276-BD765669-D40C-49AA-B279-4571B34BCD38Q39649629-47F6B38E-DC5E-46F4-91B8-5E0A4488077EQ39771455-7FDC68E8-85CD-4DED-8B3E-E8AA70A4E126Q39878425-B8CC82C9-4910-4067-B50E-3860BA6AB5A8Q39918654-2563C670-10FD-458B-94FA-C1F5596AE79EQ40410702-171B6718-CF68-4EF5-B4EA-9832EA2BBB96Q41119411-8403BC48-D6ED-4B0B-845F-589A0344B0A1Q41634881-9A6802AE-B0B2-42DC-8836-DF7A51B95523Q42132649-23AD9642-43EC-4906-8C84-C3FE1A06F124Q42459849-1C3C2404-95AF-4C57-9922-C04C076ED65CQ42695284-33750976-6715-4182-B29B-1B628A6DD88FQ42703302-2D42917B-6F03-4E49-82C9-BE9C98D3FB02Q42714372-34E16867-51AA-4250-86A8-D4F0D3E6F5CDQ42731747-B3233A82-3423-4DD0-9FEB-C4C733E53DF9Q43866819-DEAFD1FB-205A-4F29-8467-5A9616522484Q43876764-C44B867F-FC8D-4FBD-8603-00059247BF3AQ44138514-4D7881F8-F0B5-4BBB-AA07-44F5D9307C27Q44473165-2F658E22-E5EF-474B-A3BF-51619304454EQ44473547-B8870253-ADB0-4ED0-B603-2482BCEEC18AQ44475694-47519A35-2C30-40E6-8480-AAA0E9D71387Q44629104-6B26DFF5-3DB7-49A7-ABCD-F17604C7BA2AQ44648915-F38D2F48-EEDF-4407-A7C0-79000D362AF8Q45211547-E9EA824E-3EE9-4896-8793-53026318A330
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Oliver Zolk
@ast
Oliver Zolk
@en
Oliver Zolk
@es
Oliver Zolk
@nl
Oliver Zolk
@sl
type
label
Oliver Zolk
@ast
Oliver Zolk
@en
Oliver Zolk
@es
Oliver Zolk
@nl
Oliver Zolk
@sl
prefLabel
Oliver Zolk
@ast
Oliver Zolk
@en
Oliver Zolk
@es
Oliver Zolk
@nl
Oliver Zolk
@sl
P214
P106
P1153
6603846806
P21
P214
P31
P4012
P496
0000-0002-8220-3834
P735
P7859
viaf-35195470